Special Issue "New Challenges in HPV Vaccination and Cancer Prevention"
Deadline for manuscript submissions: 31 December 2023 | Viewed by 4112
2. Obstetrics and Gynecology Department, UAM University, Madrid, Spain
3. Biomedical Research Institute – IdiPAZ, Madrid, Spain
Interests: gynecologic oncology; cervical cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue in Cancers: Advances in the Diagnosis and Management of Uterine Sarcomas
Special Issue in Current Oncology: Advances in the Diagnosis and Management of Uterine Sarcomas
The HPV vaccine has been established as the best option among prevention strategies to avoid the development of cervical cancer in women worldwide. During the last decade, we have observed a great evolution in HPV vaccines, such as the increase in HPV serotype coverage, but also in their strategic implementation expanding to more extreme age ranges. Investigating the challenges associated with therapeutic HPV vaccines may open a new horizon in the fight against cervical cancer. In parallel, knowledge about the etiopathogenesis, transmission mechanisms, and evolution of the disease have been changing in recent years as well. All these research lines and new findings make this Special Issue an opportunity to communicate promising research lines, new concepts, results of immunization on different populations (based on age, previous surgical treatments, immunosuppressed patients, etc.), and every single development related to HPV vaccines.
We hope all authors and researchers consider this opportunity to publish their work in this Vaccines journal.
Dr. Ignacio Zapardiel
Dr. Jesus de la Fuente Valero
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cervical cancer
- therapeutic vaccines